Sections

With an initial seed investment of $12 million, Optain becomes the first company announced in Ascertain's growing portfolio of AI companies.

As part of the deal, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply its machine learning techniques to facilitate the drug efficacy assessment process

Users of Ascensia's world-renowned CONTOUR BGM portfolio will now be able to seamlessly incorporate SNAQ into their diabetes management regimen

The relationship will give consumers lower-cost medications and diabetes testing supplies and more personalized, higher-quality care

This article delves deep into the challenges surrounding billing and coding for OBGYN (Obstetrics and Gynecology) practices outsourced medical billing, offering practical solutions and best practices to overcome such hurdles...

Nursing education has changed dramatically over the past few decades, with technology playing a big role...

As healthcare professionals, nurses are at the forefront of patient care and often work long hours in high-pressure environments...

As a nursing educator, you can shape the next wave of aspiring nurses...

This blog post provides an overview of the latest advancements in digital therapeutics, focusing on key clinical trials and the role of Contract Research Organizations (CROs) in facilitating their execution...

The combined entity will be called XRHealth and will have 500K VR treatments, exceed 25K patients treated, and be deployed by over 2500 clinicians